Dr. Green is an Endocrinologist and Professor of Medicine at Duke University and a member of the Duke Clinical Research Institute (DCRI). Her research has focused upon strategies to treat diabetes mellitus and reduce the risk of CV, kidney and other complications. She is an Executive Committee Member for GRADE, a long-term comparative effectiveness study of medications for T2D, and has held leadership roles in numerous large, international trials studying the CV effects of newer glucose-lowering medications (including TECOS, EXSCEL, and Harmony Outcomes). She is Executive Committee member, PI of the US coordinating center, and country representative for the global EMPA-Kidney and EASi-Kidney trials. She has held multiple roles with the American Diabetes Association, including serving on the organization’s Professional Practice Committee, as a member of the ADA-EASD consensus statement writing group, and as an Associate Editor of Diabetes Care.